These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Radiotherapy and oral capecitabine in the preoperative treatment of patients with rectal cancer: rationale, preliminary results and perspectives. Corvò R; Pastrone I; Scolaro T; Marcenaro M; Berretta L; Chiara S Tumori; 2003; 89(4):361-7. PubMed ID: 14606636 [TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial. Allegra CJ; Yothers G; O'Connell MJ; Beart RW; Wozniak TF; Pitot HC; Shields AF; Landry JC; Ryan DP; Arora A; Evans LS; Bahary N; Soori G; Eakle JF; Robertson JM; Moore DF; Mullane MR; Marchello BT; Ward PJ; Sharif S; Roh MS; Wolmark N J Natl Cancer Inst; 2015 Nov; 107(11):. PubMed ID: 26374429 [TBL] [Abstract][Full Text] [Related]
4. Capecitabine and radiotherapy as neoadjuvant treatment for rectal cancer. Ben-Josef E Am J Clin Oncol; 2007 Dec; 30(6):649-55. PubMed ID: 18091061 [TBL] [Abstract][Full Text] [Related]
5. Preoperative chemoradiotherapy for rectal cancer: a comparison between intravenous 5-fluorouracil and oral capecitabine. Ramani VS; Sun Myint A; Montazeri A; Wong H Colorectal Dis; 2010 Aug; 12 Suppl 2():37-46. PubMed ID: 20618366 [TBL] [Abstract][Full Text] [Related]
6. Preoperative capecitabine and pelvic radiation in locally advanced rectal cancer--is it equivalent to 5-FU infusion plus leucovorin and radiotherapy? Chan AK; Wong AO; Jenken DA Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1413-9. PubMed ID: 20338475 [TBL] [Abstract][Full Text] [Related]
7. Risk-adapted adjuvant chemotherapy after concomitant fluoropyrimidine-radiotherapy neoadjuvant treatment for patients with resectable cT3-4 or N+ rectal cancer. Sastre J; Custodio A; Sanchez JC; Ortega L; Rodriguez L; Puente J; Corona J; Alfonso R; de las Heras M; Dıaz-Rubio E Anticancer Drugs; 2011 Feb; 22(2):185-90. PubMed ID: 21218606 [TBL] [Abstract][Full Text] [Related]
8. The role of capecitabine in locally advanced rectal cancer treatment: an update. Fernández-Martos C; Nogué M; Cejas P; Moreno-García V; Machancoses AH; Feliu J Drugs; 2012 May; 72(8):1057-73. PubMed ID: 22621694 [TBL] [Abstract][Full Text] [Related]
9. Evolving role of neoadjuvant therapy in rectal cancer. Schrag D Curr Treat Options Oncol; 2013 Sep; 14(3):350-64. PubMed ID: 23828092 [TBL] [Abstract][Full Text] [Related]
10. The use of capecitabine in the combined-modality therapy for rectal cancer. Liauw SL; Minsky BD Clin Colorectal Cancer; 2008 Mar; 7(2):99-104. PubMed ID: 18501068 [TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial. Dunst J; Debus J; Rudat V; Wulf J; Budach W; Hoelscher T; Reese T; Mose S; Roedel C; Zuehlke H; Hinke A Strahlenther Onkol; 2008 Sep; 184(9):450-6. PubMed ID: 19016023 [TBL] [Abstract][Full Text] [Related]
12. Chemoradiotherapy for rectal cancer--is there an optimal combination? Glimelius B Ann Oncol; 2001 Aug; 12(8):1039-45. PubMed ID: 11583178 [TBL] [Abstract][Full Text] [Related]
13. Capecitabine chemoradiation for rectal cancer after curative surgery. Bajetta E; Beretta E; Di Bartolomeo M; Mariani L; Valvo F; Ferrario E; Mancin M; Dognini G; Buzzoni R J Chemother; 2006 Feb; 18(1):85-9. PubMed ID: 16572898 [TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. Chau I; Brown G; Cunningham D; Tait D; Wotherspoon A; Norman AR; Tebbutt N; Hill M; Ross PJ; Massey A; Oates J J Clin Oncol; 2006 Feb; 24(4):668-74. PubMed ID: 16446339 [TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy and rectal cancer]. Michel P; Di Fiore F Cancer Radiother; 2011 Oct; 15(6-7):436-9. PubMed ID: 21885319 [TBL] [Abstract][Full Text] [Related]
16. The integration of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: how successful have we been? Glynne-Jones R; Dunst J; Sebag-Montefiore D Ann Oncol; 2006 Mar; 17(3):361-71. PubMed ID: 16500912 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the efficacy of oral capecitabine versus bolus 5-FU in preoperative radiotherapy of locally advanced rectal cancer. Kim JS; Kim JS; Cho MJ; Yoon WH; Song KS J Korean Med Sci; 2006 Feb; 21(1):52-7. PubMed ID: 16479065 [TBL] [Abstract][Full Text] [Related]
18. Postoperative XELOX therapy for patients with curatively resected high-risk stage II and stage III rectal cancer without preoperative chemoradiation: a prospective, multicenter, open-label, single-arm phase II study. Mizushima T; Ikeda M; Kato T; Ikeda A; Nishimura J; Hata T; Matsuda C; Satoh T; Mori M; Doki Y BMC Cancer; 2019 Sep; 19(1):929. PubMed ID: 31533662 [TBL] [Abstract][Full Text] [Related]
19. Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis. Das P; Lin EH; Bhatia S; Skibber JM; Rodriguez-Bigas MA; Feig BW; Chang GJ; Hoff PM; Eng C; Wolff RA; Delclos ME; Krishnan S; Janjan NA; Crane CH Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1378-83. PubMed ID: 17056196 [TBL] [Abstract][Full Text] [Related]
20. Preoperative capecitabine with pelvic radiotherapy for locally advanced rectal cancer (phase I trial). Veerasarn V; Phromratanapongse P; Lorvidhaya V; Lertsanguansinchai P; Lertbutsayanukul C; Panichevaluk A; Boonnuch W; Chinswangwatanakul V; Lohsiriwat D; Rojanasakul A; Thavichaigarn P; Jivapaisarnpong P J Med Assoc Thai; 2006 Nov; 89(11):1874-84. PubMed ID: 17205868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]